Published in World J Gastroenterol on August 21, 2008
Patterns of lymph node metastasis are different in colon and rectal carcinomas. World J Gastroenterol (2010) 0.96
A mutator phenotype in cancer. Cancer Res (2001) 4.41
Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem (1996) 3.95
Molecular organization of the uvomorulin-catenin complex. J Cell Biol (1992) 3.46
The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest (2002) 3.23
Quantitative analysis of cadherin-catenin-actin reorganization during development of cell-cell adhesion. J Cell Biol (1996) 2.73
The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology (2000) 2.04
MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res (2004) 1.77
Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res (2001) 1.70
Immunohistochemical detection of alpha-catenin expression in human cancers. Am J Pathol (1994) 1.40
beta-catenin expression in primary and metastatic colorectal carcinoma. Int J Cancer (1999) 1.36
Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer. Int J Cancer (2007) 1.31
Expression of sFRP-4 and beta-catenin in human colorectal carcinoma. Cancer Lett (2006) 1.15
Mechanisms of metastasis. Crit Rev Oncol Hematol (1997) 1.09
Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer. Br J Cancer (1999) 1.07
Expression of E-cadherin and alpha-catenin in patients with colorectal carcinoma. Correlation with cancer invasion and metastasis. Am J Clin Pathol (1999) 1.05
E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome. World J Gastroenterol (2006) 1.03
The expression of E-cadherin and catenins in sporadic colorectal carcinoma. Hum Pathol (2001) 0.99
Prognostication of invasive ductal breast cancer by quantification of E-cadherin immunostaining: the methodology and clinical relevance. Histopathology (2002) 0.95
Patterns of alpha- and beta-catenin and E-cadherin expression in colorectal adenomas and carcinomas. J Pathol (1997) 0.94
Role of the E-cadherin/alpha-catenin complex in modulating cell-cell and cell-matrix adhesive properties of invasive colon carcinoma cells. Ann Surg Oncol (1995) 0.91
The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients. J Pathol (2002) 0.88
Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract. Virchows Arch (2002) 0.87
Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer. Br J Cancer (1998) 0.84
Expression and prognostic value of alpha-, beta-, and gamma-catenins indifferentiated thyroid carcinoma. J Clin Endocrinol Metab (2000) 0.80
Reduced E-cadherin and alpha-catenin expressions have no prognostic role in bladder carcinoma. Pathol Oncol Res (2006) 0.79
Oral mucosa as a reservoir of human papillomavirus: point prevalence, genotype distribution, and incident infections among males in a 7-year prospective study. Eur Urol (2012) 3.38
High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin Cancer Res (2005) 3.38
BRAF mutations in metastatic melanoma: a possible association with clinical outcome. Clin Cancer Res (2003) 3.21
Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer. Acta Cytol (2006) 1.42
Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study. Int J Cancer (2010) 1.34
Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints. Anticancer Res (2005) 1.25
Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Hum Pathol (2008) 1.25
High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer (2002) 1.17
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis. Anticancer Res (2014) 1.17
Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear. Gynecol Oncol (2005) 1.14
Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinoma. World J Gastroenterol (2008) 1.12
Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients. Parkinsonism Relat Disord (2008) 1.10
VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival. Anticancer Res (2009) 1.06
Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma. Melanoma Res (2004) 1.05
Diagnosis delay in Libyan female breast cancer. BMC Res Notes (2012) 1.05
MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients. Cancer Invest (2010) 1.04
Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors. BMC Res Notes (2009) 1.03
A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma. Melanoma Res (2010) 1.03
Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecol Oncol (2003) 1.02
Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis. Anticancer Res (2009) 1.01
Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy. J Gen Virol (2009) 1.01
Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins. Infect Agent Cancer (2006) 0.99
Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection. Scand J Infect Dis (2008) 0.98
Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. Head Neck (2006) 0.96
Comparison of DNA sequencing and Roche Linear array in human papillomavirus (HPV) genotyping. Anticancer Res (2006) 0.94
Increased risk of oncogenic human papillomavirus infections and incident high-grade cervical intraepithelial neoplasia among smokers: experience from the Latin American screening study. Sex Transm Dis (2009) 0.94
Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus. Int J Gynecol Pathol (2005) 0.94
Detection of oncogenic DNA viruses in colorectal cancer. Anticancer Res (2008) 0.93
Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer. Tumour Biol (2012) 0.93
Breast cancer patients in Libya: Comparison with European and central African patients. Oncol Lett (2011) 0.93
Increased gene expression levels of collagen receptor integrins are associated with decreased survival parameters in patients with advanced melanoma. Melanoma Res (2007) 0.93
Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypes. J Pediatr (2011) 0.93
Nuclear morphometry in FNABs of breast disease in Libyans. Anticancer Res (2009) 0.92
Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer. Oncol Rep (2006) 0.92
Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study). Gynecol Oncol (2012) 0.91
HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas. J Clin Virol (2011) 0.90
Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Côte d'Ivoire and Finland) with different tobacco exposure. Cancer Causes Control (2008) 0.90
Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes. Scand J Infect Dis (2010) 0.90
Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol (2005) 0.90
Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer. Am J Clin Pathol (2004) 0.90
Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma. Anticancer Res (2012) 0.89
Methylation of the polycomb group target genes is a possible biomarker for favorable prognosis in colorectal cancer. Cancer Epidemiol Biomarkers Prev (2012) 0.89
Hormonal contraceptives and the length of their use are not independent risk factors for high-risk HPV infections or high-grade CIN. Gynecol Obstet Invest (2010) 0.89
A prognostic model and staging for metastatic uveal melanoma. Cancer (2003) 0.89
Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways. Intervirology (2008) 0.89
Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the Former Soviet Union. J Clin Microbiol (2004) 0.89
Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines. Vaccine (2012) 0.88
RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency. Anticancer Res (2011) 0.88
Immunohistochemically detectable bcl-2 expression in metastatic melanoma: association with survival and treatment response. Oncology (2002) 0.88
Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: a six-year follow-up study. PLoS One (2013) 0.87
Prognostic value of proliferation markers: immunohistochemical ki-67 expression and cytometric s-phase fraction of women with breast cancer in libya. J Cancer (2012) 0.87
Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma. APMIS (2012) 0.87
High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer. Anticancer Res (2013) 0.87
Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests. Sex Transm Dis (2008) 0.87
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma. J Gastrointest Cancer (2009) 0.86
Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma. Melanoma Res (2008) 0.86
P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear. Acta Cytol (2007) 0.86
Evaluation of HER-2/neu gene amplification by fluorescence in situ hybridization and immunohistochemistry in saudi female breast cancer. Anticancer Res (2010) 0.85
Sexual habits and human papillomavirus infection among females in three New Independent States of the former Soviet Union. Sex Transm Dis (2003) 0.84
Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study. PLoS One (2012) 0.84
Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology. Virchows Arch (2012) 0.84
Nuclear morphometry in prognostication of breast cancer in Saudi Arabian patients: comparison with European and African breast cancer. Anticancer Res (2010) 0.84
Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma. World J Gastroenterol (2012) 0.84
Applicability of liquid-based cytology to the assessment of DNA content in cervical lesions using static cytometry. Anal Quant Cytol Histol (2003) 0.84
Apoptosis in breast cancer: Nigerian vs. Finnish material. Anal Quant Cytol Histol (2002) 0.84
Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma. Tumour Biol (2012) 0.84
Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort. Virchows Arch (2009) 0.84
The association of immunoreactive p53 and Ki-67 with T-stage, grade, occurrence of metastases and survival in renal cell carcinoma. Anticancer Res (2006) 0.83